INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)
$35.83 0.38 (1.0719%)
Analysed INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) News Sources
Indivior Q2 Earnings Call Highlights
03-08-2026
marketbeat.com
INDV to Merge With Supernus, Beats on Q2 Earnings, Raises '26 Outlook
04-08-2026
yahoo.com
Should Investors Buy INDV as Sublocade Growth Meets Rising Risks?
21-08-2026
yahoo.com
Indivior's Supernus Merger Could Broaden Its Growth Engine in 2026
21-08-2026
yahoo.com
Indivior Pharmaceuticals (INDV) Could Be 30% Undervalued On Its Cost Reset Plan
22-08-2026
yahoo.com
3 Reasons Why Growth Investors Shouldn't Overlook Indivior Pharmaceuticals Inc. (INDV)
27-08-2026
yahoo.com
Indivior Pharmaceuticals Inc. (INDV) Loses 12.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
31-08-2026
yahoo.com
Indivior Pharmaceuticals Inc. (INDV) Down 5.3% Since Last Earnings Report: Can It Rebound?
02-09-2026
yahoo.com
5 Small Drug Stocks Poised to Benefit From a Biotech Recovery
14-09-2026
yahoo.com
Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend
17-09-2026
yahoo.com
What is the current price of INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)?
The current price of INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) is $35.83.
INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) absolute price change since previous trading day?
The absolute price change of INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) since the previous trading day is $0.38.
INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) percentage price change since previous trading day?
The percentage price change of INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) since the previous trading day is 1.0719%.
What is the most recent average sentiment score for INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)?
The most recent average sentiment score for INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)?
The most recent sentiment for INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) is .
SEC-8K** Filing Available For INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.